Development of a New CHO Platform for the Manufacturing of Intranasal Influenza Vaccines
September 16, 2025 – Funded activities
September 16, 2025 – Funded activities
September 11, 2025 – Funded activities
As part of its Innovations in Vaccine Technologies program, Médicament Québec is investing $7.5 million to support four groundbreaking initiatives that will strengthen Quebec’s vaccine research and development capacity.
September 9, 2025 – News from Médicament Québec